Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

This clinical practice guideline is a focused update on management of Clostridioides difficile
infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for …

Clostridioides difficile infection (CDI) remains a significant clinical challenge both in the
management of severe and severe-complicated disease and the prevention of recurrence …

Clostridioides difficile infection (CDI) is the leading cause of health care–associated
infections in the United States. The increasing incidence and recurrence rates of CDI …

Abstract Background In 2018, the Infectious Diseases Society of America (IDSA) published
guidelines for diagnosis and treatment of Clostridioides (formerly Clostridium) difficile …

Clostridium difficile infection (CDI) is a potentially fatal illness with an increasing incidence
worldwide. Despite extensive ongoing research into CDI treatment, management of CDI still …

Background Clostridium difficile is the leading cause of antibiotic-associated diarrhoea, both
in healthcare facilities and in the community. The recurrence rate of C. difficile infection (CDI) …

Clostridioides (formerly: Clostridium) difficile infection (CDI) is a major cause of diarrhoea for
inpatients as well as outpatients. Usually, CDI is healthcare-associated but the number of …

Abstract In 2009 the first European Society of Clinical Microbiology and Infection (ESCMID)
treatment guidance document for Clostridium difficile infection (CDI) was published. The …

Objectives Clostridioides difficile infection (CDI), its subsequent recurrences (rCDIs), and
severe CDI (sCDI) provide a significant burden for both patients and the healthcare system …